Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
Scientific
Intravacc announces additional favorable preclinical and toxicology data for Avacc 10®, an intranasal SARS-CoV-2 candidate vaccine
Scientific
Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine
Scientific
Intravacc launches hybrid business model to drive innovation and growth
